The impact of molecular pathology in oncology: the clinician's perspective.
作者信息
Grade Marian, Becker Heinz, Ghadimi B Michael
出版信息
Cell Oncol. 2004;26(5-6):275-8. doi: 10.1155/2004/510582.
Abstract
摘要
相似文献
1
The impact of molecular pathology in oncology: the clinician's perspective.分子病理学在肿瘤学中的影响：临床医生的视角。
Cell Oncol. 2004;26(5-6):275-8. doi: 10.1155/2004/510582.
2
[New techniques and methods in oncological biology: forward to molecular biopathology].肿瘤生物学的新技术与方法：迈向分子生物病理学
Bull Cancer. 2001 Jan;88(1):9-14.
3
Translational oncology toward benefiting cancer patients: the Sun Yat-sen University Cancer Center experience.转化肿瘤学造福癌症患者：中山大学肿瘤防治中心的经验
Sci China Life Sci. 2016 Oct;59(10):1057-1062. doi: 10.1007/s11427-012-4398-4.
4
Introduction to molecular oncology.分子肿瘤学导论
Anat Pathol. 1997;2:227-38.
5
The things that matter most.最重要的事情。
Ann Surg Oncol. 2002 Oct;9(8):709-16. doi: 10.1007/BF02574490.
6
NCCN molecular testing white paper: effectiveness, efficiency, and reimbursement.NCCN 分子检测白皮书：有效性、效率和报销。
J Natl Compr Canc Netw. 2011 Dec;9 Suppl 6:S1-16. doi: 10.6004/jnccn.2011.0138.
7
8
Advances and Challenges in Pediatric and Childhood Cancers.儿科和儿童癌症的进展与挑战。
Cancer Cell. 2020 Oct 12;38(4):429-432. doi: 10.1016/j.ccell.2020.09.013.
9
It is fascinating to see how nowadays more and more knowledge of the molecular biological characteristics of the tumour lead to individualisation with surgery, radiotherapy and systemic treatment for patients with a malignancy. Introduction.如今，越来越多关于肿瘤分子生物学特征的知识如何促成针对恶性肿瘤患者的手术、放疗及全身治疗个体化，这一点令人着迷。引言。
Eur J Cancer. 2011 Sep;47 Suppl 3:xxxv. doi: 10.1016/S0959-8049(11)70140-X.
10
Zotero 插件